The impact of early neuraminidase inhibitor therapy on clinical outcomes in patients hospitalised with influenza A-related pneumonia: a multicenter, retrospective study

BACKGROUND: Guidelines emphasize prompt antiviral treatment in severe influenza patients. Although nearly a 50% of severe influenza present with pneumonia, the effect of early (≤ 2 days after illness onset) neuraminidase inhibitor (NAI) use on the clinical outcomes of influenza A-related pneumonia (...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Liang, Han, Xiudi, Li, Yan Li, Zhang, Chunxiao, Xing, Xiqian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7447583/
https://www.ncbi.nlm.nih.gov/pubmed/32842994
http://dx.doi.org/10.1186/s12879-020-05322-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7447583/
https://www.ncbi.nlm.nih.gov/pubmed/32842994
http://dx.doi.org/10.1186/s12879-020-05322-x

Ejemplares similares